Skip to main content
. 2017 Jun 2;12(6):e0178646. doi: 10.1371/journal.pone.0178646

Table 5. Lateral mobility of plasma membrane-bound GFP-tagged wildtype and mutant stomatin.

Effects of cholesterol and cytochalasin D.

Stomatin mutant Treatment Mobile fraction (MF) Recovery halftime (t1/2)
Mean (%) SE ΔMF (%) p-value Mean [s] SE Δt1/2 [s] p-value
WT none 58.6 4.4 26.7 9.4
WT -chol 53.9 7.7 - 4.7 0.9217 41.4 16.7 +14.7 0.1211
WT +chol 57.9 2.7 - 0.7 0.3673 29.4 4.2 + 2.7 0.3573
WT +cytoD 79.0 1.7 +20.4 0.0022 18.8 2.5 - 7.9 0.0330
WT -chol +cytoD 61.3 3.8 + 2.7 0.8306 33.8 11.9 + 7.1 0.7506
WT +chol +cytoD 69.1 2.1 +10.5 0.1830 20.8 4.6 - 5.9 0.1137
ΔN none 60.3 2.4 44.5 8.3
ΔN -chol 58.2 3.1 - 2.1 0.8330 49.9 12.1 + 5.4 0.3480
ΔN +chol 59.3 3.1 - 1.0 0.6186 28.9 13.5 - 15.6 0.6259
ΔN +cytoD 83.2 2.2 +22.9 <0.0001 25.6 1.4 - 18.9 0.0007
ΔN -chol +cytoD 70.7 5.4 +10.4 0.0248 34.1 14.3 - 10.4 0.7731
ΔN +chol +cytoD 83.3 2.3 +23.0 <0.0001 17.7 3.0 - 26.8 0.0003
ΔC none 88.6 5.1 17.4 5.1
ΔC -chol 85.7 2.8 - 2.9 0.1971 22.2 2.1 + 4.8 0.7227
ΔC +chol 63.0 2.5 - 25.6 <0.0001 23.9 7.0 + 6.5 0.2423
ΔC +cytoD 88.6 3.0 0.0 0.5478 21.8 5.1 + 4.4 0.9478
ΔC -chol +cytoD 87.1 2.0 - 1.5 0.2276 22.6 1.5 + 5.2 0.7656
ΔC +chol +cytoD 66.1 2.0 - 22.5 <0.0001 28.0 2.4 +10.6 0.3684
ΔCC none 69.6 1.5 29.1 3.5
ΔCC -chol 75.4 2.4 + 5.8 0.0407 26.5 3.3 - 2.6 0.4965
ΔCC +chol 64.9 2.6 - 4.7 0.1844 25.9 5.9 - 3.2 0.9956
ΔCC +cytoD 83.5 3.4 +13.9 0.0004 26.3 4.1 - 2.8 0.5032
ΔCC -chol +cytoD 77.7 2.3 + 8.1 0.0120 19.9 2.6 - 9.2 0.0175
ΔCC +chol +cytoD 72.2 2.0 + 2.6 0.4856 26.5 2.6 - 2.6 0.2969
Cys30Ser none 66.8 2.1 29.3 2.4
Cys30Ser -chol 66.7 2.2 - 0.1 0.9245 49.0 4.6 +19.7 0.0003
Cys30Ser +chol 55.8 3.7 - 11.0 0.0897 26.0 5.4 - 3.3 0.7465
Cys30Ser +cytoD 81.1 1.9 +14.3 <0.0001 26.6 2.3 - 2.7 0.5719
Cys30Ser -chol +cytoD 73.0 1.5 + 6.2 0.0392 37.3 1.8 + 8.0 0.0137
Cys30Ser +chol +cytoD 69.2 2.5 + 2.4 0.4429 17.5 2.6 - 11.8 0.0063
Arg62Ala none 77.4 2.7 28.5 2.1
Arg62Ala -chol 75.7 4.8 - 1.7 0.5329 25.7 2.8 - 2.8 0.3605
Arg62Ala +chol 59.7 2.1 - 17.7 <0.0001 22.2 2.6 - 6.3 0.0254
Arg62Ala +cytoD 83.2 4.4 + 5.8 0.1802 26.8 4.2 - 1.7 0.5700
Arg62Ala -chol +cytoD 85.4 2.7 + 8.0 0.0289 26.1 3.3 - 2.4 0.5237
Arg62Ala +chol +cytoD 75.8 2.4 - 1.6 0.7012 21.5 2.2 - 7.0 0.0750
Pro200Ala none 68.6 2.1 32.3 2.1
Pro200Ala -chol 70.7 5.7 + 2.1 0.1618 50.6 3.7 +18.3 0.0002
Pro200Ala +chol 62.8 3.0 - 5.8 0.3068 24.5 7.7 - 7.8 0.5346
Pro200Ala +cytoD 76.3 1.2 + 7.7 0.0089 19.3 1.3 - 13.0 0.0009
Pro200Ala -chol +cytoD 77.6 2.6 + 9.0 0.0048 40.7 5.2 + 8.4 0.0055
Pro200Ala +chol +cytoD 72.5 1.9 + 3.9 0.2533 28.6 2.2 - 3.7 0.7598
Pro245Ala none 78.0 2.7 34.5 2.4
Pro245Ala -chol 61.8 2.1 - 16.2 0.0005 36.0 6.1 + 1.5 0.3403
Pro245Ala +chol 66.7 5.2 - 11.3 0.1293 30.9 3.5 - 3.6 0.0279
Pro245Ala +cytoD 78.6 2.3 + 0.6 0.9900 21.2 1.3 - 13.3 <0.0001
Pro245Ala -chol +cytoD 77.7 2.6 - 0.3 0.9726 19.3 2.7 - 15.2 0.0005
Pro245Ala +chol +cytoD 74.0 1.9 - 4.0 0.2923 24.8 3.4 - 9.7 0.0695

MF, mobile fraction; t1/2, recovery half-time; ΔMF, MF-change of treated versus untreated sample; Δt1/2, t1/2-change of treated versus untreated sample; SE, standard error; WT, wildtype; ΔN, N-terminal deletion; ΔC, C-terminal deletion; ΔCC, coiled-coil deletion; chol, cholesterol; cytoD, cytochalasin D. Mean values, standard errors (SE), differences between mutants and WT values (ΔMF, Δt1/2), and p-values are given. Number of measurements for each value: n ≥ 20. The p-values indicate the significance of the differences between values of treated versus untreated samples.